JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks._老虎社区_美港股上老虎

JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.

MarketWatch2021-11-30

Cue the selling again. Moderna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Boazzz
·2021-12-01
No way
回复
1
举报
Mericula
·2021-11-30
Wow
回复
1
举报
Txfen80
·2021-11-30
Good info
回复
1
举报
bengkoon
·2021-11-30
Wow
回复
3
举报
收起
- JonLucky:
  Bull
  2021-12-01
  回复
  举报
Jeromelim
·2021-11-30
speculate
回复
3
举报
PeterYC
·2021-11-30
🧐🧐
回复
3
举报
Jimmyboy
·2021-11-30
Please like
回复
3
举报
收起
- PeterYC:
  Ok
  2021-11-30
  回复
  举报
Myname
·2021-11-30
Ok
回复
2
举报
JonLucky
·2021-11-30
Things are gonna get worse before they get better. The main goal though is surviving til the dawn breaks.
回复
1
举报
收起
- JonLucky:
  Thing is always the bettererest
  2021-12-02
  回复
  举报
- Thinn:
  Thing will get better
  2021-12-02
  回复
  举报
Evanchills
·2021-11-30
Like
回复
1
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2187352582?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-30 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2187352582","market":"us","top_or_hot":-1,"title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","media":"MarketWatch","content":"<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">网页链接</a>\n\n</div>\n","source":"lsy1603348471595","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IVV","symbol_name":"标普500指数ETF","start_time":0,"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","article_id":"2187352582","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","pubTimestamp":1638279131,"sourceInfo":{"source_id":"lsy1603348471595","name":"MarketWatch"},"weMediaInfo":null,"summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IVV":"标普500指数ETF","OXY":"西方石油","BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","BK4559":"巴菲特持仓",".IXIC":"NASDAQ Composite","SH":"标普500反向ETF","SPY":"标普500ETF","OEX":"标普100","UPRO":"三倍做多标普500ETF","BK4550":"红杉资本持仓",".SPX":"S&P 500 Index","BK4504":"桥水持仓","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF",".DJI":"道琼斯"},"translate_title":"摩根大通对2022年标普500的预测是华尔街最乐观的之一。这是它认为股市最大的风险。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OEF":0.9,"UPRO":0.9,"SSO":0.9,"SPY":0.9,"SPXU":0.9,"SH":0.9,"SDS":0.9,"OXY":0.9,"OEX":0.9,".DJI":0.9,"IVV":0.9,"ESmain":0.9,".SPX":0.9,".IXIC":0.9},"content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":609278114,"gmtCreate":1638289276611,"gmtModify":1638289279417,"author":{"id":"3567934801618469","authorId":"3567934801618469","name":"Boazzz","avatar":"https://static.tigerbbs.com/20d65f30895e0ab786dba18ca130d7c7","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3567934801618469","idStr":"3567934801618469"},"htmlText":"No way","listText":"No way","text":"No way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609278114","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609206239,"gmtCreate":1638284037142,"gmtModify":1638284037195,"author":{"id":"4099980859949520","authorId":"4099980859949520","name":"Mericula","avatar":"https://static.tigerbbs.com/563f4a7d9c81961bf4b6b36bfce6ce74","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"4099980859949520","idStr":"4099980859949520"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609206239","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609658467,"gmtCreate":1638282173657,"gmtModify":1638282173795,"author":{"id":"3586489129629376","authorId":"3586489129629376","name":"Txfen80","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586489129629376","idStr":"3586489129629376"},"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609658467","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609627868,"gmtCreate":1638281726043,"gmtModify":1638281726164,"author":{"id":"4088146696976370","authorId":"4088146696976370","name":"bengkoon","avatar":"https://static.tigerbbs.com/ee8ec0fb6d2ba6a8495d1b92f45a46fe","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"4088146696976370","idStr":"4088146696976370"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609627868","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6792321,"gmtCreate":1638319920744,"gmtModify":1638319920774,"authorId":3573703375513385,"author":{"id":3573703375513385,"idStr":"3573703375513385","authorId":3573703375513385,"name":"JonLucky","avatar":"https://static.tigerbbs.com/15afb66e92e4e4d6d1a8e9b7854e9d5e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609627868,"type":1,"supId":0,"prevId":0,"content":"<u>Bull</u>","text":"<u>Bull</u>","html":"<u>Bull</u>"}],"langContent":"CN"},{"id":609623393,"gmtCreate":1638281161619,"gmtModify":1638281161783,"author":{"id":"4087798944081960","authorId":"4087798944081960","name":"Jeromelim","avatar":"https://static.tigerbbs.com/45cd82e500d76165963f39f22aa6230e","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4087798944081960","idStr":"4087798944081960"},"htmlText":"speculate&nbsp;","listText":"speculate&nbsp;","text":"speculate","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609623393","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609668532,"gmtCreate":1638280252993,"gmtModify":1638280253124,"author":{"id":"3571448359169660","authorId":"3571448359169660","name":"PeterYC","avatar":"https://static.tigerbbs.com/9ef14f774a72b511343eb2acc028573c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571448359169660","idStr":"3571448359169660"},"htmlText":"🧐🧐","listText":"🧐🧐","text":"🧐🧐","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609668532","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609661688,"gmtCreate":1638280136578,"gmtModify":1638280136775,"author":{"id":"3582072891665879","authorId":"3582072891665879","name":"Jimmyboy","avatar":"https://static.tigerbbs.com/cb9d5d497bceb3edaca216e9eeab3c22","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582072891665879","idStr":"3582072891665879"},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609661688","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6785617,"gmtCreate":1638280262311,"gmtModify":1638280262343,"authorId":3571448359169660,"author":{"id":3571448359169660,"idStr":"3571448359169660","authorId":3571448359169660,"name":"PeterYC","avatar":"https://static.tigerbbs.com/9ef14f774a72b511343eb2acc028573c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609661688,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":609687543,"gmtCreate":1638279768552,"gmtModify":1638279768935,"author":{"id":"3575455489344050","authorId":"3575455489344050","name":"Myname","avatar":"https://static.tigerbbs.com/3fff4aa421deeb7a8d801ab27a14a82f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575455489344050","idStr":"3575455489344050"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609687543","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609687254,"gmtCreate":1638279768372,"gmtModify":1638279768824,"author":{"id":"3573703375513385","authorId":"3573703375513385","name":"JonLucky","avatar":"https://static.tigerbbs.com/15afb66e92e4e4d6d1a8e9b7854e9d5e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573703375513385","idStr":"3573703375513385"},"htmlText":"Things are gonna get worse before they get better. The main goal though is surviving til the dawn breaks.","listText":"Things are gonna get worse before they get better. The main goal though is surviving til the dawn breaks.","text":"Things are gonna get worse before they get better. The main goal though is surviving til the dawn breaks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609687254","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6807624,"gmtCreate":1638407736840,"gmtModify":1638407736868,"authorId":3573703375513385,"author":{"id":3573703375513385,"idStr":"3573703375513385","authorId":3573703375513385,"name":"JonLucky","avatar":"https://static.tigerbbs.com/15afb66e92e4e4d6d1a8e9b7854e9d5e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609687254,"type":1,"supId":6803025,"prevId":0,"content":"Thing is always the bettererest","text":"Thing is always the bettererest","html":"Thing is always the bettererest"},{"id":6803025,"gmtCreate":1638377285657,"gmtModify":1638377285749,"authorId":3573644992811813,"author":{"id":3573644992811813,"idStr":"3573644992811813","authorId":3573644992811813,"name":"Thinn","avatar":"https://static.tigerbbs.com/d9266b5e702b2469d0dced7310ef80e3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609687254,"type":1,"supId":0,"prevId":0,"content":"Thing will get better","text":"Thing will get better","html":"Thing will get better"}],"langContent":"CN"},{"id":609682980,"gmtCreate":1638279379990,"gmtModify":1638279380062,"author":{"id":"3577782004325702","authorId":"3577782004325702","name":"Evanchills","avatar":"https://static.tigerbbs.com/fda6badb7336a9249a031585d040ffde","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3577782004325702","idStr":"3577782004325702"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609682980","repostId":2187352582,"repostType":4,"repost":{"id":"2187352582","pubTimestamp":1638279131,"share":"https://www.laohu8.com/m/news/2187352582?lang=&edition=full","pubTime":"2021-11-30 21:32","market":"us","language":"en","title":"JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2187352582","media":"MarketWatch","summary":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a predic","content":"<p>Cue the selling again.</p>\n<p>Moderna&nbsp;CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"</p>\n<p>Initial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.</p>\n<p>Indeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&amp;P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.</p>\n<p>A JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.</p>\n<p>The team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.</p>\n<p>\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.</p>\n<p>The bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.</p>\n<p>Most of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.</p>\n<p>As for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.</p>\n<p><img src=\"https://static.tigerbbs.com/796e545cf3aa9d6923a076dd661e3c9a\" tg-width=\"700\" tg-height=\"381\" width=\"100%\" height=\"auto\"></p>\n<p>A few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour&nbsp;and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands <a href=\"https://laohu8.com/S/LVS\">$(LVS)$</a> and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes&nbsp;and Occidental Petroleum.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan's S&P 500 forecast for 2022 is among the most bullish on Wall Street. Here's the biggest risk it sees for stocks.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 21:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/jpmorgans-s-p-500-forecast-for-2022-is-among-the-most-bullish-on-wall-street-heres-the-biggest-risk-it-sees-for-stocks-11638273921?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187352582","content_text":"Cue the selling again.\nModerna CEO Stéphane Bancel brought the mood down early Tuesday with a prediction that current COVID-19 vaccines will struggle against the omicron coronavirus variant, due to its high mutations, and that it will take months to mass produce new immunizations.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" he told the Financial Times, adding that \"all the scientists I've talked to...are like 'this is not going to be good.'\"\nInitial reports of \"mild\" symptoms among some South African patients helped cheer markets on Monday. \"In reality, the evidence is still incredibly limited on this question, and nothing from the Moderna CEO overnight changes that,\" said strategist Jim Reid and his team at Deutsche Bank, whose poll showed just 10% of investors see the variant as a major market threat by year-end.\nIndeed, the show must go on, with Wall Street banks continuing to churn out forecasts for the coming year. In our call of the day, JPMorgan predicts a 5,050 finish in 2022 for the S&P 500 , which matches RBC's forecast and looks among the most optimistic on Wall Street so far.\nA JPM team led by Dubravko Lakos-Bujas, chief U.S. equity strategist, sees further stock upside ahead, albeit more moderate, on better-than-expected earnings growth, easing supply shocks, improved background on China (which JPM upgraded to overweight on expectations for policy easing and as equity risk premiums from regulatory moves are priced in) and emerging markets, normalizing consumer spending habits and, most important, accommodative central banks.\nThe team offered some comfort over recent market stress. \"While there have been sporadic setbacks with COVID-19 variants (e.g. delta, omicron), this needs to be seen in the context of higher natural and vaccine-acquired immunity, significantly lower mortality, and new antiviral treatments,\" said the team, which hammered home the important role of central banks.\n\"With this in mind, the key risk to our outlook is a hawkish shift in CB [central bank] policy, especially if post-pandemic dislocations persist (e.g. further delay in China reopening, supply-chain issues, labor shortages continue),\" said Lakos-Bujas and the team.\nThe bank sees \"broadly accommodative\" Federal Reserve policy despite tapering, and especially ahead of next November's midterm elections, with an extra $1.1 trillion in developed market central bank balance sheet expansion through 2022. It expects \"inflation rotation rather than broad-based accelerated in prices,\" and sees record corporate liquidity driving capital investment, shareholder returns and mergers and acquisitions.\nMost of the upside for U.S. stocks should be seen between now and the first half of 2022, \"when monetary and fiscal policy tailwinds will be strongest, followed by sideways action in 2H22,\" when Fed liftoff could drive some de-risking and intra-cycle correction.\nAs for stocks and sectors, the bank likes long equity exposure to rising oil prices (the bank predicts oil prices will hit $150 by 2023), financials, consumer services, healthcare and small-caps. The travel, leisure and experiences theme has \"extremely attractive risk-reward, while momentum is \"again getting increasingly correlated and crowded with growth stocks,\" the bank cautioned.\n\nA few stocks that ended up on its charts included a batch of global beneficiaries of easing supply-chain pressures -- Dollar Tree, Tapestry, Johnson Controls, Masco, Under Armour and Tyson Foods. Among those that stand to benefit from a global reopening in services are Disney, Las Vegas Sands $(LVS)$ and Expedia (EXPE). Beneficiaries of higher oil prices include Halliburton, Baker Hughes and Occidental Petroleum.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":61,"commentSize":10,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}